Cenduit LLC has introduced a new study simulation and forecasting service designed to allow clinical trial sites to better plan and control supplies for patients. The new service is integrated with the company’s interactive response technology (IRT).
 
“Clinical trials are more complex than ever and a robust and reliable clinical trial supply strategy is vital to study success,” said Jogin Desai, Cenduit’s chief executive officer. “The simulation and forecasting models, integrated with the patient randomization and drug allocation services inherent in our IRT systems, allow the complete coordination of procurement, packaging and logistics, with supply requirements from the sites themselves continuously factored in.”
 
Mr. Desai added that new system helps minimize the risk of drug supply overage and shortages at sites and helps accelerate drug development through increased supply chain productivity.